Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
October 2006
2006:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2007 | 2008
News | News in brief | News Features
News
Polish scientists fight creationism
50 leading scientists in Poland have signed an open letter in protest against an aggressive anti-evolution campaign launched by the Polish government's ultra-right-wing coalition partner.
Nature (26 October 2006)
| Full Text |
From hive minds to humans
After the sequencing of the bee genome, it might be possible to infer human gene functions in areas like social behavior from the functions of their bee analogues.
Nature (26 October 2006)
| Full Text |
Grants fall victim to NIH success
The annual budget for the National Institutes of Health (NIH) doubled between 1998 and 2003, but many researchers are finding it far more difficult to win grants.
Nature (26 October 2006)
| Full Text |
Funding agencies toughen stance on open access
The Howard Hughes Medical Institute (HHMI), a non-profit research organization that funds more than 300 researchers, is considering a plan to pressure its investigators into making their published papers freely accessible.
Nature (26 October 2006)
| Full Text |
Missing results might have rung warning bell over trial drug
Drug-safety experts call for more rigorous risk assessments after an antibody drug trial left six volunteers critically ill.
Nature (19 October 2006)
| Full Text |
Kudos, not cash, is the real X-factor
The first private team that sequences 100 human genomes in 10 days will win the Archon X Prize of US$10 million. But the real gain is publicity not money.
Nature (19 October 2006)
| Full Text |
Japan's new premier chases innovation
Japan's new prime minister has appointed a vocal supporter of science as his special adviser to boost technology - but how much will really change?
Nature (19 October 2006)
| Full Text |
Protests mount against Libyan trial
Lawyers defending six medical workers who risk execution in Libya on charges of deliberately infecting more than 400 children with HIV have called for the scientific community's support.
Nature (12 October 2006)
| Full Text |
Nobel prize blurs boundaries
This year's Nobel Prize in Chemistry went to Roger Kornberg for solving the crystal structure of RNA polymerase II — "But is it chemistry?" ask chemists.
Nature (12 October 2006)
| Full Text |
Genentech raises stakes on PARP inhibitors
The recent, eye-catching entry of Genentech into the poly (ADP-Ribose) polymerase (PARP) inhibition space underlines the potential of a field that is long on scientific promise
Nature Biotechnology (October 2006)
| Full Text |
Polyclonal antibodies step out of the shadows
After decades in the shadow of monoclonal antibodies, therapeutic polyclonal antibodies are undergoing a renaissance.
Nature Biotechnology (October 2006)
| Full Text |
Scientists eye embryo-free methods to derive stem cells
Popular approaches aim to reset molecular switches that define an embryonic state.
Nature Medicine (October 2006)
| Full Text |
WHO's next?
The race for the WHO's next leader is unexpectedly crowded.
Nature Medicine (October 2006)
| Full Text |
Spain's ill-conceived project leaves its scientists in the lurch
Those who returned to Spain for Ramón y Cajal fellowships are scrambling for jobs.
Nature Medicine (October 2006)
| Full Text |
Youthful duo snags a swift Nobel for RNA control of genes
Craig Mello and Andrew Fire receive the 2006 Nobel Prize for their discovery of RNAi.
Nature (5 October 2006)
| Full Text |
Cloners break away from the herd
Differentiated blood cells can be reprogrammed easier and yield more clones than hematopoietic stem cells.
Nature (5 October 2006)
| Full Text |
Wikipedia rival calls in the experts
Citizendium, a rival encyclopedia to wikipedia, aims to recognize the status of its academic editors.
Nature (5 October 2006)
| Full Text |
News in brief
Agent of Singapore's drive to biomedicine steps down
| FDA urged to assess cloned animals like drugs
| Cell biologist takes on PNAS editorship
| Sanger Institute to shed staff in strategy rethink
| Japan reforms screening to speed up drug approval
| Institute allocates $3bn of stem-cell research spend
| Multidisciplinary staff proves winning combination
| Representatives call for NIH structural overhaul
| Scientists push for stronger voice in Congress
News Features
Cell biology: Power games
Cytochrome oxidase is a key player in a new understanding of how a cell's energy metabolism affects health and disease.
Nature (26 October 2006)
| Full Text |
Marine natural products: Drugs from the deep
William Fenical from the Californian Scripps Institute is among the group of researchers who believe that the search for disease cures from the ocean depths has just started.
Nature (26 October 2006)
| Full Text |
US election: Showdown for Capitol Hill
Science does not rank first among political issues for US citizens, but their voting behavior in the midterm elections will change the scientific landscape.
Nature (19 October 2006)
| Full Text |
Q&A
Physicist Rush Holt, one of the few scientists in Congress, strives for promoting science in politics and building a sense of respect for government.
Nature (19 October 2006)
| Full Text |
A life online
Darwin's complete works are now freely available on the web, giving us the chance to rethink our knowledge about his theories.
Nature (19 October 2006)
| Full Text |
Depression: Comfortably numb
It started life as an anesthetic, then became a psychedelic club drug. Now researchers think ketamine could hold the key to understanding and treating depression.
Nature (12 October 2006)
| Full Text |
Turning plants into protein factories
Companies making proteins in plants are cooking along, while the agbiotech continues to give itself a black eye.
Nature Biotechnology (October 2006)
| Full Text |
News feature: Crime and punishment
DNA is often the most incriminating evidence in a courtroom but sloppy analysis has sent dozens of innocent people to prison.
Nature Medicine (October 2006)
| Full Text |
Environmental activism: In the name of nature
Environmentalists attack research laboratories because of a deep doubt about the reformability of our industrial culture.
Nature (05 October 2006)
| Full Text |
Copycats gear up to dog biotech brands
Pressure is mounting on US regulators to create an approval track for generic versions of biotechnology drugs.
Nature (05 October 2006)
| Full Text |
|
